These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33596666)

  • 1. Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization.
    De Rossi G; Vähätupa M; Cristante E; Arokiasamy S; Liyanage SE; May U; Pellinen L; Uusitalo-Järvinen H; Bainbridge JW; Järvinen TAH; Whiteford JR
    Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1374-1389. PubMed ID: 33596666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.
    Liyanage SE; Fantin A; Villacampa P; Lange CA; Denti L; Cristante E; Smith AJ; Ali RR; Luhmann UF; Bainbridge JW; Ruhrberg C
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):19-24. PubMed ID: 26603154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents that bind annexin A2 suppress ocular neovascularization.
    Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
    J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
    Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
    Elife; 2020 Apr; 9():. PubMed ID: 32312382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
    Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
    Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
    Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
    Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
    Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
    Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1.
    Luo L; Uehara H; Zhang X; Das SK; Olsen T; Holt D; Simonis JM; Jackman K; Singh N; Miya TR; Huang W; Ahmed F; Bastos-Carvalho A; Le YZ; Mamalis C; Chiodo VA; Hauswirth WW; Baffi J; Lacal PM; Orecchia A; Ferrara N; Gao G; Young-Hee K; Fu Y; Owen L; Albuquerque R; Baehr W; Thomas K; Li DY; Chalam KV; Shibuya M; Grisanti S; Wilson DJ; Ambati J; Ambati BK
    Elife; 2013 Jun; 2():e00324. PubMed ID: 23795287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
    Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
    FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside diphosphate kinase B regulates angiogenesis through modulation of vascular endothelial growth factor receptor type 2 and endothelial adherens junction proteins.
    Feng Y; Gross S; Wolf NM; Butenschön VM; Qiu Y; Devraj K; Liebner S; Kroll J; Skolnik EY; Hammes HP; Wieland T
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2292-300. PubMed ID: 25147336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization.
    Ikeuchi T; Kanan Y; Long D; de Vega S; Hozumi K; Nomizu M; Campochiaro PA; Yamada Y
    Microvasc Res; 2020 May; 129():103986. PubMed ID: 32017943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
    Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Cells Require CD98 for Efficient Angiogenesis-Brief Report.
    Liao Z; Cantor JM
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2163-2166. PubMed ID: 27687603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
    Duan J; Du C; Shi Y; Liu D; Ma J
    Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mini-TyrRS-induced angiogenesis response in endothelial cells by VE-cadherin-dependent mini-TrpRS.
    Zeng R; Chen YC; Zeng Z; Liu XX; Liu R; Qiang O; Li X
    Heart Vessels; 2012 Mar; 27(2):193-201. PubMed ID: 21442253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial TWIST1 promotes pathological ocular angiogenesis.
    Li J; Liu CH; Sun Y; Gong Y; Fu Z; Evans LP; Tian KT; Juan AM; Hurst CG; Mammoto A; Chen J
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8267-77. PubMed ID: 25414194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.